Skip to content

Establishing a single disease clinical database of severe fever with thrombocytopenia syndrome in Shandong province.

Analysis of Prognostic Risk Factors for Sever Fever with Thrombocytopenia Syndrome:A single center, retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086176
Enrollment
Unknown
Registered
2024-06-26
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Fever with Thrombocytopenia Syndrome

Interventions

Survival Group:Not applicable, no interventions.
Death Group:Not applicable, no interventions.
Critical Group:Not applicable, no interventions.
Non-critical Group:Not applicable, no interventions.

Sponsors

Shandong Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosed with SFTS by clinical doctors based on the diagnostic criteria from the Guidelines for Prevention and Treatment of Severe Fever with Thrombocytopenia Syndrome (2010 edition) and the Diagnosis and Treatment Plan for Severe Fever with Thrombocytopenia Syndrome (2023 edition) issued by the Ministry of Health of the People's Republic of China, with at least one positive serum SFTSV-PCR result.

Exclusion criteria

Exclusion criteria: 1. Patients with a hospital stay of less than 72 hours (indicating mild or critical condition, which does not reflect the early stage of the disease); 2. Patients co-infected with COVID-19, hepatitis C virus, Brucella, Mycobacterium tuberculosis, suspected HIV, or syphilis.

Design outcomes

Primary

MeasureTime frame
conditions of prognosis;

Secondary

MeasureTime frame
Demographic information;Clinical laboratory test indicators during hospitalization;Changes of clinical symptoms during hospitalization;

Countries

China

Contacts

Public ContactLirui Tu

Shandong Public Health Clinical Center

tulirui83237@163.com+86 132 2058 5081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026